Work

Abstract PS3-11-07: Real-world use of neratinib in her2-positive early breast cancer in korea: updated follow-up from a multicenter observational study

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps3-11-07

Authors: S. Kim, S. Kim, K. Shin, J. Lee, J. Kim, Y. Moon

Institutions: CHA University Bundang Medical Center, CHA University, Samsung Changwon Hospital, Sungkyunkwan University, The Catholic University of Korea Seoul St. Mary's Hospital, Catholic University of Korea, Yonsei University, Gangnam Severance Hospital

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129335980

Cites:

Cited by:

Related to: